Valuation : Medclair AB

Market Cap 268M 27.97M 24.07M 22.65M 20.69M 38.7M 2.64B 38.81M 104M 1.36B 105M 103M 4.37B P/E 2024
-138x
P/E 2025 49.7x
Enterprise Value 262M 27.37M 23.55M 22.16M 20.24M 37.87M 2.58B 37.97M 102M 1.33B 103M 101M 4.27B EV / Sales 2024
3.09x
EV / Sales 2025 4.28x
Free-Float
8.9%
Yield 2024 *
-
Yield 2025 -
1 day-1.35%
1 week+1.04%
Current month+1.04%
1 month+4.66%
3 months+21.67%
6 months+26.96%
Current year-2.01%
1 week 2.89
Extreme 2.89
3.1
1 month 2.8
Extreme 2.8
3.1
Current year 2.2
Extreme 2.2
3.12
1 year 2.2
Extreme 2.2
3.35
3 years 1.08
Extreme 1.08
3.35
5 years 1.08
Extreme 1.08
3.35
10 years 0.85
Extreme 0.85
3.46
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2026-06-03
Chief Tech/Sci/R&D Officer 62 -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 50 2009-12-31
Director/Board Member 50 2023-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.35%+1.04%-8.18%+151.72% 28.4M
+1.42%+2.26%+95.99%+144.41% 54.92B
+4.27%+1.78%+155.91%+158.22% 16.88B
-6.57%-17.33%+239.60%+257.71% 16.81B
+2.40%+2.96%+40.61%+31.11% 10.23B
-4.83%-12.96%+179.96%+106.63% 8.21B
-0.95%-2.41%+16.54%+62.44% 8.05B
+0.05%-1.06%+34.79%+156.86% 7.1B
+1.76%-0.94%-4.08%+20.72% 7.08B
+1.15%+2.84%+48.31% - 6.94B
Average -0.27%-3.92%+79.95%+121.09% 13.62B
Weighted average by Cap. +0.28%-3.82%+106.51%+138.39%

Financials

2024 2025
Net sales 35.95M 3.76M 3.23M 3.04M 2.78M 5.2M 355M 5.21M 13.95M 182M 14.11M 13.8M 586M 56.06M 5.86M 5.04M 4.74M 4.33M 8.11M 553M 8.13M 21.76M 284M 22.01M 21.53M 915M
Net income -664K -69.41K -59.72K -56.19K -51.33K -96.02K -6.55M -96.29K -258K -3.36M -261K -255K -10.83M 4.65M 486K 419K 394K 360K 673K 45.92M 675K 1.81M 23.56M 1.83M 1.79M 75.9M
Net Debt -2.58M -270K -232K -219K -200K -374K -25.49M -375K -1M -13.08M -1.01M -992K -42.13M -5.74M -600K -516K -486K -444K -830K -56.64M -832K -2.23M -29.06M -2.25M -2.2M -93.62M
Logo Medclair AB
Medclair AB, formerly known as Medclair Invest AB, is a Sweden-based company primarily engaged in research and development. The Company’s scope of activities revolves around measurement, collection, and destruction of Nitrous Oxide (N2O). What is more, the Company is specialized in catalytic gas purification as well as is involved in processes that are related to gas purification and gas measurement, ventilation, and control. Given the Firm’s operations associated with Nitrous Oxide, which can serve the purpose of a short-acting sedative, its customers mainly comprise of establishments active in the healthcare industry, which include maternity wards, children’s healthcare facilities, as well as dental care facilities.
Employees
15
Date Price Change Volume
26-09-04 SEK 2.920 -1.35% 106,860
26-09-03 SEK 2.960 -3.27% 95,553
26-09-02 SEK 3.060 -1.29% 299,853
26-09-01 SEK 3.100 +7.27% 696,108
26-08-31 SEK 2.890 0.00% 124,497
  1. Stock Market
  2. Stocks
  3. MCLR Stock